Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lung Cancer
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 40 years and 74 years
- Gender
- Both males and females
Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening process to determine eligibility of study entry. Peripheral blood, tissue sample and imaging examinations of eligible patients will be collected for further analysis. Data ...
After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening process to determine eligibility of study entry. Peripheral blood, tissue sample and imaging examinations of eligible patients will be collected for further analysis. Data collected will be used to develop a multi-omics lung cancer diagnosis model.
Tracking Information
- NCT #
- NCT04817046
- Collaborators
- Not Provided
- Investigators
- Study Chair: Fan Yang, MD Peking University People's Hospital
Get Well Soon